DE SCR88

Designates May 1-8, 2022, as "Tardive Dyskinesia Awareness Week" in Delaware during National Mental Health Awareness Month.

Identifies Tardive Dyskinesia as a movement disorder affecting people treated for mental health conditions including schizophrenia, bipolar disorder, and severe depression.

Notes that antipsychotic medications can cause Tardive Dyskinesia in one out of every four patients receiving long-term treatment, with symptoms including involuntary muscle movements that are often permanent.

Acknowledges the Food and Drug Administration recently approved two new treatments for Tardive Dyskinesia symptoms following scientific breakthroughs.

Encourages all Delawareans to become better informed about Tardive Dyskinesia, with over 600,000 Americans diagnosed and many more unaware or misdiagnosed.